Sort
10,766 grants matching “checkpoint inhibitor”
Targeting CD5 on Tumor-associated T and B cells to improve PD-1 blockade in Breast Cancer
$452,540Chunyan Zhang · Beckman Research Institute/City Of Hope · R21 · FY2020 · CA
RCAN 1.4 metastasis suppressor in thyroid cancer
$452,487Matthew D Ringel · Ohio State University · R01 · FY2020 · CA
Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer
$452,277Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer
$452,277Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Mathematical Model-Guided Adoptive Immunotherapy in Bladder Cancer
$452,237Katarzyna Anna Rejniak · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Vaccine Targeting of RCC Blood Vessels to Promote TME Normalization and Enhance TIL Recruitment
$452,135Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Vaccine Targeting of RCC Blood Vessels to Promote TME Normalization and Enhance TIL Recruitment
$452,135Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Epigenetic Regulation of Head and Neck Cancer Immune Evasion
$452,097Chao Lu · Columbia University Health Sciences · R01 · FY2022 · DE
qHTS of Patient Derived HCC Models to Identify Novel Probes/Therapeutic Agents
$452,096Paul A. Johnston · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Targeting apoptotic caspases to enhance cancer radiotherapy
$452,079Chuan-Yuan Li · Duke University · R01 · FY2019 · CA
Improving anti-tumor immunity in advanced breast cancer by targeting solid stress
$451,940Dennis Jones · Boston University Medical Campus · R01 · FY2024 · CA
Developing newly combined therapeutic strategies for mature B cell lymphoma
$451,877Jing Hong Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Project 2: Combination PARPi-BETi to Overcome PARPi Resistance
$451,827Haider Mahdi · University Of Pittsburgh At Pittsburgh · P50 · FY2023 · CA
[18F]-AraG -PET imaging to evaluate immunological response to checkpoint inhibitor therapy (CKI) in patients with advanced solid tumors
$451,542Shivaani Kummar · Oregon Health & Science University · R01 · FY2021 · CA
Engineered Ensemble Nanoimmunotherapies for Cancer
$451,530Rohan Fernandes · George Washington University · R37 · FY2023 · CA
Mechanisms of Nucleic Acid Enzymes - Pol Beta, HIV-1 Reverse Transcriptase and Mammalian Base Repair Enzymes
$451,397Samuel H Wilson · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
Immunostimulatory Nanocarrier for Breast Cancer Immunochemotherapy
$451,366Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · CA
Cell-Selective CpG-STAT3 Inhibitors for Radioimmunotherapy of Malignant Glioma
$451,162Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Novel immune suppressive activities of Fas/CD95 in triple negative breast cancer
$451,069Marcus E Peter · Northwestern University At Chicago · R01 · FY2023 · CA
Epigenetic regulation of exhausted CD8 T cells via the miR-29a-TET2 axis
$451,004Erietta Stelekati · University Of Miami School Of Medicine · R01 · FY2025 · AI
Deciphering the mechanism of response to novel HPV-specific viral immune therapy in HPV associated head and neck cancer
$451,000Evgeny (eugene) G Izumchenko · University Of Chicago · R21 · FY2025 · DE
Overcoming vaccine-associated hypoxia with advanced biomaterials to enhance cancer immunotherapy
$450,986Stephen Matthew Hatfield · Northeastern University · R01 · FY2023 · EB
Impact of Leukemia Microenvironment on Response to Targeted Therapies in AML
$450,830Anupriya Agarwal · Oregon Health & Science University · U54 · FY2019 · CA
Is ERBB4 a Driver of BRAF WT Melanomas?
$450,826David J. Riese · Auburn University At Auburn · R15 · FY2024 · CA
F-Box Proteins: Deregulated Cell Cycle Control and Proteolysis in Cancer
$450,674Michele Pagano · New York University School Of Medicine · R01 · FY2019 · CA